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Multisite phosphorylationConnexins require an integrated network for protein synthesis, assembly, gating, internalization, degradation
and feedback control that are necessary to regulate the biosynthesis, and turnover of gap junction channels.
At the most fundamental level, the introduction of sequence-altering, modiﬁcations introduces changes in
protein conformation, activity, charge, stability and localization. Understanding the sites, patterns and mag-
nitude of protein post-translational modiﬁcation, including phosphorylation, is absolutely critical. Historical-
ly, the examination of connexin phosphorylation has been placed within the context that one or small
number of sites of modiﬁcation strictly corresponds to one molecular function. However, the release of
high-proﬁle proteomic datasets appears to challenge this dogma by demonstrating connexins undergo mul-
tiple levels of multi-site phosphorylation. With the growing prominence of mass spectrometry in biology and
medicine, we are now getting a glimpse of the richness of connexin phosphate signals. Having implications to
health and disease, this review provides an overview of technologies in the context of targeted and discovery
proteomics, and further discusses how these techniques are being applied to “ﬁll the gaps” in understanding
of connexin post-translational control. This article is part of a Special Issue entitled: The Communicating junc-
tions, roles and dysfunctions.
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The connexin (Cx) family of proteins are required for a range of bi-
ological processes including embryonic development [1,2], homeosta-
sis [3,4], calcium signaling [5], cell migration [2,6] and apoptosis [7]. As
a tetraspan-integral membrane protein, resident of the secretory
pathway and principal component of gap junctions (GJs), Cx require
an integrated network for protein synthesis, transport, assembly, gat-
ing, internalization, degradation and feedback control, with each stage
likely to be critical in the control of GJ intercellular communication. As
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phosphorylation/dephosphorylation is thought to occur as Cx sub-
units are trafﬁcked from one cellular compartment to the other
[8–12]. The life-span of most Cxs is incredibly short, and Fig. 1 gives
a simpliﬁed, but a generally accepted summary related to the “timing”
of GJ subunit assembly and turnover. This review starts by discussing
how mass spectrometry (MS)-based proteomics may be used to “ﬁll
the gaps” in our understanding of GJ/Cx regulation. The speciﬁc roles
of Cx phosphorylation have been recently discussed [9,10,13], and
the purpose of this review is to introduce how proteomics may be ap-
plied to better understand the functions, sites, magnitude and se-
quence of multi-site phosphorylation that encompass the ‘Cx code’.
The molecular heterogeneity of a protein's post-translational
modiﬁcation (PTM) is inﬂuenced by, and dependent upon, an inter-
play of enzymes, physiological conditions and the cell-/tissue-type.
At the most fundamental level, the introduction of sequence-
altering modiﬁcations, either dynamic (e.g. phosphorylation, ubiqui-
tylation) or non-reversible (e.g., cleavage, degradation), introduces
changes in protein conformation, activity, charge, stability and locali-
zation. Furthermore, with more than ten different phosphorylation-
speciﬁc protein-binding domains [14], the addition of phosphate to
one or multiple amino acid residues often modulates docking sites
for protein–protein interactions. By SDS-PAGE, Cx43 typically forms
multiple bands between ~37 and ~45 kDa, with the fastest migrating
species recognized as non-phosphorylated protein. In the early stages
of Cx43 assembly the protein is largely non-phosphorylated [11],
with extensive modiﬁcation occurring only after transport to the
plasma membrane [15]. Despite the wealth of information related to
Cx phosphorylation, our current body of knowledge related to Cx
PTMs and their impact on function is often viewed as incomplete,
and at times, contradictory [16]. Although monitoring the state of
phosphorylation by SDS-PAGE has proven to be useful for Cx43, itFig. 1. Overview of the GJ life-cycle, depicting the relative order and timing of Cx sub-
units. Newly synthesized Cxs undergo synthesis within the ER undergo quality control
within the ER-associated degradation pathway (ERAD). Subunits passing this stage un-
dergo vesicular transport to the Golgi where they are oligomerized into heximeric
“connexons”. From here, connexon enriched vesicles are delivered to the plasma mem-
brane where they dock at sites of cell-to-cell contact to establish or maintain sites of GJ
intercellular communication (GJIC). While at GJs, Cxs-bind to an array of proteins, in-
cluding cytoskeletal proteins (ZO-1, ZO-2, MUPP1, actin, drebrin, tubulin), transcrip-
tion factors (ZONAB) and a variety of signaling kinases and phosphatases that are
thought scaffold channels and potentiate GJ communication levels. A mechanism of
GJ degradation involves internalization as double membrane structures called annular
GJs that interface with the lysosome and/or proteasome. Most Cxs examined thus far
demonstrate a half-life on the order of 1–5.5 h. Such rates of production and turnover,
alongside complex patterns of assembly and trafﬁcking, are consistent with a highly in-
tegrated system.should be noted not all phosphoproteins demonstrate detectable
electrophoretic shifts, and the identity of individual site(s) and mod-
ifying enzyme(s) largely remain unresolved. Driven by the hypothesis
that one or a small set of individual sites correspond to one molecular
function, the determination of phospho-sites historically required the
use of P32 radiolabels/2D gels, phospho-speciﬁc antibodies, nullifying
site-directed conversion of Ser/Thr to Ala or Tyr to Phe, and/or
phospho-mimetic mutations to Asp or Glu. The precise role of individ-
ual sites of modiﬁcation alone or in combination within speciﬁc sub-
cellular locales has been difﬁcult to pinpoint because of the lack of
side chain analogs that allow one to investigate functional contribu-
tions of phosphorylation alone. For example, it important to consider
that substitution of Ser/Thr/Try to Ala or Phe not only lacks the ability
to accept phosphate, but also increases hydrophobicity by displacing
the position's ability to accept hydrogen bonds with water. With
varying degrees of success [17–21], discussions regarding Glu/Asp
phospho-mimetics largely center on obvious differences in the num-
ber of oxygen atoms/hydrogen bonds, geometry, numbers of negative
charge at neutral pH, size and the lack of a natural pTyr isostere [22].
While individual sites of phosphorylation may be sufﬁcient to induce
an on/off response, compounding these challenges PTMs have also re-
cently been found to work in a cooperative manner [23,24]. Best ex-
empliﬁed by gene regulation and the histone code, core histones are
reversibly modulated by synergistic phosphorylation, acetylation,
methylation and ubiquitylation [25,26]. With similar hypotheses hav-
ing also been put forward for p53 [27] and tubulin [28], it is now clear
multi-site PTMs represent an important mechanism for cell signal
transduction. For Cx43 sequence harboring 66 Ser/Thr/Tyr residues,
with the majority of conﬁrmed sites residing in the cytoplasmic
carboxyl-terminal tail (CT), it is important to recognize that a single
Cx43 subunit may encompass upwards of 10^92 (66!) possible
phosphate-based signaling combinations. It is clear the consequences
of multi-site phosphorylation with respect to Cx trafﬁcking/life-cycle
and GJ gating have yet to be fully appreciated.
2. Proteomics
In its most classical deﬁnition, a proteome is deﬁned as the set of
proteins expressed by a genome [29,30]. While omic-based ap-
proaches to address speciﬁc research questions are often described
as “ﬁshing experiments”, these strategies have their merits as they
provide an unbiased view of biology that could otherwise never
have been predicted. Proteomics technology is improving rapidly
and now endeavors to systematically examine protein expression,
structure, function, protein–protein interaction and dynamics. The
proteome is highly dynamic, with a broad range of individual protein
concentrations ranging from several million to only a few copies/cell
[31]. Although sub-stoichiometric phosphorylation may be sufﬁcient
to induce a robust biological signal [32,33], the detection of discrete
changes in protein phosphorylation amongst the bulk proteome are
not trivial. In general, to identify a protein by high-performance liquid
chromatography-tandem mass spectrometry (HPLC-MS/MS), the in-
strument should be able to (i) determine the peptide's mass, (ii) frag-
ment the peptide and analyze fragment mass, and in some instances,
(iii) quantify expression or level of biochemical enrichment (Fig. 2).
The lack of time for stages i and ii due to the complexity of digests
makes sample preparation an important feature of most proteomic
endeavors. An ongoing theme in the ﬁeld is to therefore increase an-
alytical sensitivity, by increasing instrumental speed and/or fraction-
ation of the proteome by chemical, biochemical and genetic methods
[34–36].
3. Mass spectrometry (MS)
The ﬁrst step in proteomic analysis involves reducing proteins to
peptides with an endoproteinase, such as trypsin. Cleaving carboxy-
Fig. 2. Stages of proteomic experiment. A) MS of Cx43 peptide SDPYHATTGPLSPSK (A.A. 244–258) that was isotope-encoded by heavy dimethylation to provide a measure biochem-
ical enrichment relative to irrelevant IgG immunoprecipitation (IP) negative control. Monoisotopic mass 1621.8738 (m/z 811.4405, blue) and 2 Da isolation window used for pep-
tide selection for MS/MS (yellow). B) MS/MS CID fragmentation of SDPYHATTGPLSPSK (Mascot peptide score 68) identify peaks primarily assigned to the y-ion (C-terminal) series
that corresponds to breakage of the peptide (C\N) bond. Experimentally measured [M+H+]=1621.8738, theoretical mass [M+H]=1621.8678. C) Summary of quantiﬁed Cx43
peptides using a box plot of Cx43 peptides from experimental and negative control IPs. Here, chromatograms for each isotope-encoded peptides pair are reconstructed to derive
integrated peak areas. The peptide ratio chart shows the spread (log2 fold change) of quantiﬁed peptides of Cx43 (IP) and enrichment relative to this control. Added in equal
amounts, trypsin peptides demonstrate the expected log2~0 (ratio ~1). MS and MS/MS measurements obtained on an LTQ-OrbitrapXL (ThermoFisher, Germany). Spectra and
quantiﬁcation charts derived using Proteome Discoverer 1.3 (ThermoFisher, Germany). Protein IDs derived with Mascot 2.3 (MatrixScience, USA).
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able size and charge that further augments efﬁciency of HPLC and
measurement by MS. Most modern-day MS systems are comprised
of 4 major components: 1) HPLC, 2) the ion source, 3) the mass ana-
lyzer and 4) the detector. At the heart of this system is the ion source,
where peptides acquire charge and are transferred into the gas phase.
Until the mid-1980s, the underlying problem in biological MS was
how to get peptides, proteins and other large biomolecules into the
gas phase without extensive decomposition. Recognized by a Nobel
Prize (2002), breakthroughs by John Fenn (electrospray ionization,
ESI) and Kochi Tanaka (light-desorption ionization) have provided
signiﬁcant contributions that have enabled the unbiased, high-
throughput detection of peptides and proteins. Commonly used em-
bodiments of these sources now include nano-electrospray (nESI)
[37], and matrix-assisted laser desorption-ionization (MALDI) [38]
developed by Franz Hillenkamp and Michael Karas.
The principal outcome of most proteomics experiments is the
identiﬁcation of proteins and the use of high-accuracy, high-
precision mass analyzers is therefore necessary to increase the conﬁ-
dence of results. Within the mass spectrometer, gas phase ions are
separated and characterized based on their behavior within electricor magnetic ﬁelds. It is important to note that MS does not measure
the mass, but instead measures mass-to-charge ratio (m/z) of pep-
tides, and their diagnostic fragments by tandem-MS, a.k.a. MS/MS. In-
formation garnered from MS and MS/MS measurements is used to
identify proteins and isolate important sites of PTM. Primary se-
quence information can be obtained by MS/MS were peptides are dis-
sociated by introducing intermolecular collisions with a neutral gas
(e.g. He, Ar, or N2) and analyzing the resulting fragments in a process
called collision-induced dissociation (CID). Peptide breakage during a
CID experiment generally occurs through the lowest energy pathway
to produce a series of fragment ions containing either the C-terminal
(designated x-, y-, or z-ion), or N-terminal ions (a-, b-, or c-ion). For
the case of CID, this mode of fragmentation usually results in the
cleavage of the peptide (C\N) bond to generate b-/y-ions ion frag-
ment series. To designate the position of the fragment within the
polyamino acid sequence, each series of ions is numerically designat-
ed — with position 1 identifying the absolute C-/N-terminal amino
acid within the original sequence. The described nomenclature for
peptide fragmentation is summarized in Fig. 3.
Several different types of MS/MS-enabled instruments are now
available, and such instruments now include tandem-in-time (such
Fig. 3. A) Nomenclature for peptide fragmentation. Positional cleavage along the peptide backbone results in C- (x-, y-, z-) or N-terminal (a-, b-, c-) ions. CID experiments typically
follow b-/y-ions, while ECD and ETD-type fragmentation typically produce c- and z-type ions. B) MRM detection of Cx43 peptide VAAGHELQPLAIVDQRPSSR (A.A. 347–366) from
lysates of C6 glioma cells by CID-MS/MS. C) Overview of a MRM-QQQ experiment. During an MRM run, Q1 selects peptides based on m/z for transfer to the Q2 CID collision cell.
Product ions, called transitions, are then speciﬁcally selected as they pass through a Q3 isolation window. Each set of transitions at a given LC-elution time uniquely identiﬁes a
target protein.
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poles). In theory, MS and MS/MSmeasurements can be used to exam-
ine any PTM leading to a difference in mass. For example, the addition
of a phosphate to Ser/Thr/Tyr residue is expected to yield a mass in-
crease of 79.9 Da. For enrichment, chromatographic approaches for
phosphopeptide analysis generally take advantage of their negative
charge (e.g. strong cation (SCX)/anion exchange) [39,40], or afﬁnity
for either metal oxides (e.g. TiO2) [41], or metal cations (immobilized
metal afﬁnity chromatography, IMAC) [42]. For quantitative experi-
ments, isotope-encoded reference peptides (e.g. Aqua [43]), chemical
modiﬁcations (dimethylation [44]) or metabolic labeling (SILAC [45])
all allow accurate evaluation of protein and PTM levels between and
within samples. To a high-level of analytical precision, the incorpora-
tion of these internal standards permits the high-throughput exami-
nation of protein dynamics related to a time course and/or a drug
treatment. While there are numerous types of mass analyzer conﬁgu-
rations that are capable of doing MS-based experiments, this review
will primarily focus on triple-quadrupole (QQQ), quadrupole–quad-
rupole-time-of-ﬂight (QQTOF) and orbital/ion traps instruments.
4. Discovery proteomics: linear trapping quadrupole— orbital trap
LTQ-Orbitrap is an example of a hybrid instrument employing an
orbital trapping device [46] used in parallel with a linear trapping
quadrupole (LTQ). In the orbital trap, ions orbit around a central elec-
trode and oscillate harmonically at a frequency characteristic of their
m/z. The movements of these ions induce a mirroring current on the
outer surface of the device. Monitored frequencies of these currents
undergo Fourier transformation to generate high-resolution MS spec-
tra of intact peptides at accurate mass. Simultaneous with these mea-
surements, the LTQ component of the mass spectrometer is
responsible for the fast generation of sequence-dependant data byrepeatedly selecting, fragmenting, and analyzing peptides by CID
where fragment ions are sequentially ejected, strike a detector, and
recorded. With the aim of enhancing the detection of phosphorylated
peptides, complementary modes of MS/MS analysis have now been
developed [47]. In contrast to CID, electron-transfer (ETD) and
electron-capture dissociation (ECD) proceeds through a mechanism
of electron transfer to induce bond rearrangement and spontaneous
cleavage of the peptide backbone. This mode of MS/MS preferentially
generates c- and z-type fragment ions (Fig. 3). Permitting direct se-
quencing by MS/MS, an important advantage of ETD/ECD is the con-
nectivity of labile phosphates can now be maintained [47,48].
5. Discovery proteomics: quadrupole quadrupole time-of-ﬂight
(QQTOF)
A quadrupole (Q) mass analyzer effectively functions as anm/z ﬁl-
ter. Depending on their m/z, ions ﬂowing into a quadrupole either
have a stable trajectory to reach the detector, or have unstable
paths and effectively lost. Alternatively, when operated in ‘RF-only’
mode, these devices may serve as ion guides that permit all ions to
pass that are particularly useful as “collision cells” for CID. In a typical
quadrupole quadrupole time-of-ﬂight (QQTOF) instrument, Q1 serves
as mass selector, Q2 collision cell, with the TOF component used to
measure the m/z intact peptide and resulting MS/MS fragments [49].
The TOF analyzer itself is unique in the fact it analyzes ions based
on their travel within a ﬁeld free drift tube of known length. Drift in
this tube permits ion ‘ﬂight times’ to be measured and m/z to be cal-
culated after impact with the detector. As all ions receive the same
amount of kinetic energy, ions of smaller m/z travel faster to reach
the detector ﬁrst. Another beneﬁt of the QQTOF conﬁguration is the
ability to examine the full complement of MS/MS fragments within
a single TOF scan. Relevant to further discussions, as the mechanisms
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discovery on QQTOF make them ideally suited for follow up examina-
tion by targeted proteomics using triple quadrupole (a.k.a. “triple
quad” or QQQ) instrumentation.
6. Database searches and signiﬁcance in discovery proteomics
Another important and evolving aspect of discovery proteomics is
the processing and interpreting the enormous amounts of MS and
MS/MS data. The identity of a protein can be unveiled by several dif-
ferent methods for identiﬁcation, however it should be mentioned
the increasing abundance and quality of genomic data sets has greatly
simpliﬁed these procedures. Historically, protein identities could be
revealed by accurately measured masses of intact peptides that
were matched against a theoretical list of in silico digested protein.
This method, known as peptide mass ﬁngerprinting or PMF [50],
was highly successful for rapidly identifying moderately pure pro-
teins originating from a 2D-PAGE spot or a narrow SDS-PAGE band
[51]. A caveat to the PMF approach however is that peptides masses
together contribute to the reliability of a protein identiﬁcation and
the examination of protein mixtures, or even LC separated peptide
materials often confounds identiﬁcation due to the detection of back-
ground proteins. Furthermore, as no direct sequence information can
be directly derived fromMS-only/PMF data (e.g. peptide HPYTGK will
have the same m/z as GTYPHK), these methods cannot be used to
conﬁdently assign peptide sequences, or differentiate a peptide carry-
ing a PTM from unrelated peptide of similar mass. Due to the limita-
tions of MS-only information, instrumentation capable of MS/MS
sequencing in combination with the accurate mass measurements
have largely replaced single-stage MS in proteomics.
The modern-day standard for protein/PTM identiﬁcation is now
based on measuring intact peptide and the resulting fragment ions
generated by MS/MS. It is important to note that the presentation of
a list of proteins by the search engine is preceded by two important
procedures: 1) assigning peptide sequences to proteins, and 2) the
separation of correct from incorrect peptide identiﬁcations. During a
typical MS/MS experiment, fragmentation information (i.e. intensities
and m/z values of all the peaks) from each MS/MS spectrum is sub-
mitted to a database search engine, which in turn tries to assign a
peptide sequence to a spectrum. Many such MS/MS database search
engines exist [52]. Two popular ones, Mascot [53] and Sequest [54],
identify peptides using probability-based and autocorrelation algo-
rithms, respectively. In general, these two programs score a peptide
fragment ion spectrum based upon how well they match against a
theoretical fragment spectra constructed from candidate peptide se-
quences within a database. This group of candidate peptides depends
on user-deﬁned criteria such as mass tolerances, proteolytic enzymes
and possible modiﬁcations. Each of these candidates is given a (search
engine dependant) score and ranked accordingly. However, since the
aim of most experiments is to identify protein, the identiﬁcation of
peptide sequences only represents an intermediate step. Difﬁculties
of assembling sequences into protein ID arise from the fact that pro-
teins are digested with a protease. This loss of connectivity compli-
cates computational analysis and biological interpretation, especially
when a peptide is ambiguously found in multiple proteins [55].
Under ideal situations, the identiﬁcation of a discriminating peptide
can be used for veriﬁcation [51]. However, in the absence of such a di-
agnostic sequence, alternate enzyme(s), targeted proteomic methods
(as discussed in subsequent sections), or application of alternate
methods to increase sequence coverage may be beneﬁcial.
Incorrect peptide identiﬁcations can be the result of a substantial
overlap between the experimental MS/MS ion spectrum and a theo-
retical fragment spectrum from an unrelated precursor that results
in a chance random match or so-called “false-positive”. Since there
is a substantial overlap between correct and incorrect identiﬁcations,
it is necessary to ﬁnd a balance between sensitivity (increasing true-positives) and speciﬁcity (minimizing false-positives). The latter can
be examined by searching against a “decoy” database or where pro-
tein sequences are reversed [56], shufﬂed [57] or by using random se-
quences [58]. The number of identiﬁcations from the target-decoy
search strategy is used to calculate a false discovery rate (FDR),
which is deﬁned as the percentage of accepted identiﬁcations that
are incorrect, and to describe the statistical signiﬁcance of the identi-
ﬁcations [59,60]. These procedures are necessary to obtain an inde-
pendent measure of dataset reliability. Alongside target-decoy
searches, ‘in silico’ proteome should also include sequences for
human (e.g. keratins) and other commonly observed experimental
contaminants (e.g. from bovine serum/culture media, trypsin).
It is important to note that protein identiﬁcation algorithms, such
as MASCOT and Sequest, make the ﬁrst and foremost assumption that
the correct sequences for identiﬁcation are amongst those being
searched. Failure to include all possible sources of protein, either by
searching against an irrelevant or searching against an artiﬁcially
small database, will result in the search engine assigning the highest
scoring incorrect sequence as the most reliable answer [61,62]. A re-
cent study by Locke et al. reported the PTM of Cx26 to identify more
than 15 sites of PTM (acetylation, hydroxylation, carboxyglutamation,
methylation and phosphorylation), at sites of deafness-causing Cx26
mutations [63]. Here, materials originating from human Hela cells,
were searched against a database of “connexin only” sequences or a
database containing rodent sequences (parameters: 20–40 kDa, pI
0–14, mass tolerance 50 ppm) [63]. Even at the reported conﬁdence
search interval (95%), such a search would very likely generate an a
high number of false-positive identiﬁcations for of the following rea-
sons: 1) MS data was searched against an artiﬁcially small database
containing only Cx sequences; 2) The majority of PTMs assigned by
this study were solely based on accurate mass (the accepted method
for PTM site assignment is MS/MS); and 3) Failure to consider human
sequences, alongside common contaminants (Cx26 materials were
originally obtained from Hela cells). For protein identiﬁcation, it is
very important to stress, that database search programs have all pos-
sible sequences to be available for comparison to MS-generated data.
Restricting the search space to one, or an artiﬁcially small handful of
proteins, will result in all spectra being matched back to the one/
limited number sequences. In fairness to this study, the re-
evaluation of raw data ﬁles using an appropriate database (in silico
proteome, reverse sequences and contaminants) will be necessary
to determine the absolute reliability of PTMs/Cx26 peptides reported.
To avoid potential pitfalls, the proteomic community strongly advo-
cates against the use of similar ‘Cx only’ databases or the use of
single-stage MS data to assign sites of PTM control.
6.1. Targeted proteomics: triple-quadrupole (QQQ) MS/MS
Due to complexity of the proteome and limitations of discovery-
based MS data acquisitions, a major drawback to discovery-based
proteomics is the lack of consistency between sample runs. However,
recent applications in proteomics have resulted in the delivery of an-
alytical strategies that permit a set of proteins to be consistently mea-
sured across multiple samples [64]. When a speciﬁc target is known, a
method called multiple-reaction monitoring (MRM, also called
selected-reaction monitoring or SRM), Fig. 3B and C, has emerged as
a highly sensitive and reproducible technique, even across different
labs and manufacturer platforms [65]. These types of detections
have the beneﬁt of multiplexing, molecular resolution, absolute quan-
titation, low-attomole sensitivity and dynamic range upwards of ﬁve
orders of magnitude [66]. During an MRM analysis, Q1 is instructed to
repeatedly sweep through a list ofm/z corresponding to peptide(s) of
interest. As only one speciﬁc peptide m/z will be allowed to enter the
(Q2) CID collision cell, with only selected fragments ions (called tran-
sitions) being recorded, the MRM approach permits a subset of pro-
teins to be reproducibly recorded. As multiple levels of molecular
28 V.C. Chen et al. / Biochimica et Biophysica Acta 1828 (2013) 23–34ﬁltering are now utilized (HPLC-retention time, selected peptide m/z,
and selected peptide fragment m/z), these detections are both highly
selective and sensitive. Furthermore, as each set of transitions at a
speciﬁc HPLC elution time uniquely identiﬁes a peptide, the area
under an ion chromatogram curve provides a direct quantitative mea-
sure. Recently, public repositories and tools including PeptideAtlas
(www.peptideatlas.org) [67], Global Proteome Machine (GPM,
www.gpm.org), Protein identiﬁcation Database (www.ebi.ac.uk/
pride/) [68,69] and the Sequence-speciﬁc Retention Time Calculator
(http://hs2.proteome.ca/SSRCalc/SSRCalcX.html) [70] have been de-
veloped with the aim of annotating protein expression [71] and deci-
phering protein-based signals by MRM [72]. Demonstrating the
potential of this technology to identify (QQTOF) and track (QQQ)
phosphorylation dynamics with phosphotyrosine-IPs and IMAC
enrichment, Wolf-Yadlin et al. followed the temporal proﬁles of 222
tyrosine phosphorylation sites across seven time points after EGF
treatment [73]. Developing a simpliﬁed method to quantifying
the absolute stoichiometry of protein phosphorylation by MRM,
Domanski et al. developed a novel approach based upon the addition
of single isotope-encoded non-phosphorylated synthetic peptide
and enzymatic dephosphorylation. Relative increases in non-
phosphorylated peptide with alkaline phosphatase treatment provid-
ed an absolute measure of protein residing in the phosphorylated
from [74]. However as phosphorylated species are collapsed to it's
unmodiﬁed native form, it should be noted that contribution from in-
dividual multi-phosphorylated sites cannot be distinguished using
this method.
As only a certain set of representative peptides will be detectable
within a complex mixture by MRM, selection of peptides and their
most abundant fragment ions will be absolutely critical [64]. To expe-
dite the use of MRMs in Cx expression proﬁling and similar phosphor-
ylation stoichiometry studies, our lab has developed a list of Cx43Table 1
Cx43 MRM Transitions.
Sequence (A.A.), species SSRCal:
hydrophobicity [108]
Precursor
(m/z)
YGIEEHGK
(137–144)
Ms, Rat, Hu
9.42 466.9++
311.6+++
SDPYHATTGPLSPSK
(244–258)
Ms, Rat
19.06 520.2+++
779.6++
SFPISHVR
(249–256)
Ms, Rat, Hu
22.15 471.9++
315+++
GDWSALGK (2–9*)
Ms, Rat, Hu
20.56 417.4++
VAAGHELQPLAIVDQRPSSR
(348–366)
Ms, Rat, Hu
31.1 537.1++++
715.7+++
TYIISILFK
(154–162)
Ms, Rat, Hu
44.58 549.5++
+=H+ charge state (+1, 2, 3 or 4), SILAC: K=+4.025107, R=+6.020129, * n-terminal M
elution time of peptides in targeted proteomic studies. Developed by Oleg Krokhin (Univers
chromatography [108]. Precursor values are m/z of intact peptides use by Q1. Fragment m/
toring by Q3. Ion fragment type and charge state (+, ++, +++) are provided.peptide transitions (Table 1). From immunoprecipitation of Cx43
(b1% FDR), we have compiled consistently and conﬁdently identiﬁed
peptides by LC-MS/MS. These peptides were chemically synthesized
and analyzed by QQQ-MS/MS to determine the most abundant/
sensitive fragments for MRM transition selection. More speciﬁcally,
we have employed solid phase chemical synthesis (Intavis MultiPep,
Germany) to manufacture Cx peptides (Table 2) for MS/MS examina-
tion on a CHiP-QQQ (Aglient 6400 series, 1200 series HPLC, USA). For
example, peptide VAAGHELQPLAIVDQRPSSR (Fig. 3) demonstrates
the uses of these transitions in the detection of Cx43 from cell lysates
from C6 glioma cells. Here, HPLC retention time and abundance of
transitions (percent area y12, y4 and y10) from whole cell lysates
match the expected values from synthesized standards.
6.2. Multi-site phosphorylation
Cx43 has been shown to be a substrate for MAPK, PKC, CaMK and
c-/v-SRC [74–78]. As the process of PTM generates a potentially dis-
tinct functional entity, a principal question related to this work is
how does phosphorylation by kinases and phosphatases regulate
Cxs? Amongst others, work by Laird, Musil, Nagy, Lau, Kardami and
Lampe laboratories have established the importance of phosphoryla-
tion for Cx subcellular trafﬁcking, GJ gating, function and turnover. To
enrich for plasma membrane proteins, Wisniewski et al. developed
methods to isolate ion channels and transporters and identiﬁed
more than 12,000 phosphorylation sites on 4579 brain proteins, in-
cluding numerous sites within Cx43, Cx32, Cx47 and Cx29 [79].
With the aim of better understanding the role of phosphorylation in
different organs, using a combination of SCX and metal-afﬁnity en-
richment, Huttlin et al. examined phosphorylation patterns in
mouse heart, brain, fat, kidney, pancreas, testes, spleen, lung and
liver [34]. This study found upwards of 36,000 phosphorylation sitesFragment
(m/z)
Precursor
(SILAC: K4/R6)
Fragment
(SILAC: K4/R6)
Ion
769.4 468.9++ 773.4 y7
599.0 603.0 y5
712.4 716.4 y6
599.2 312.9+++ 603.2 y5
385.3 387.3 y7++
341.3 345.3 y3
678.4 521.5+++ 680.4 y13++
452.6 453.9 y13+++
418.2 422.2 y4
678.3 781.6++ 680.3 y13++
958.4 962.4 y10
887.3 891.3 y9
708.4 474.9++ 714.4 y6
498.3 504.3 y4
354.8 357.8 y6++
611.4 317+++ 617.4 y5
498.3 504.3 y4
354.8 357.8 y6++
661.4 419.4++ 665.4 y6
475.3 479.3 y5
331.2 333.2 y6++
669.9 538.6++++ 672.9 y12++
564.8 567.8 y10++
446.9 448.9 y12+++
669.9 717.7+++ 672.9 y12++
365.7 368.7 y6++
855.0 858.0 y15++
833.6 551.5++ 837.6 y7
720.4 724.4 y6
607.4 611.4 y5
removal. SSRCal is a hydrophobicity index used to order and accurately predict HPLC
ity of Manitoba), the higher the value, the later the peptide will elute by reverse-phase
z present the top 3 highest abundance/most sensitive ions generated by Q2, for moni-
Table 2
Cx43 site and multi-site phosphorylation.
Region Site Target-based methods Site/multi-site Cx43 phosphorylation
NT Ser5 GDWpS(5)ALGK*
CT Ser244 [16]
CT Tyr247 [109] SDPpY(247)HATTGPLSPSK*
CT Ser/Thr250 SDPYHATpT(250)GPLSPSKDCGpS(262)PK•
CT Thr251 SDPYHATpS(251)GALSPAK*
SDPYHATpS(251)GALpS(255)PAK°
CT Ser255 [13,76] SDPYHATSGALpS(255)PAK•
SDPYHATpS(251)GALpS(255)PAK°
SDPYHATTGPLpS(255)PSKDCGpS(262)PK•
CT Ser257 [16] SDPYHATTGPLSPpS(257)KDCGSPK•
CT Ser262 [101,110] SDPYHATpT(250)GPLSPSKDCGpS(262)PK•
SDPYHATTGPLpS(255)PSKDCGpS(262)PK•
CT Tyr265 [111] pY(265)AYFNGCSSPTAPLSPMpS(282)PPGYK•
CT Ser273 YAYFNGCSpS(273)PTAPLSPMSPPGYK•
YAYFNGCSpS(273)PpT(275)APLSPMSPPGYK•
CT Thr275 YAYFNGCSpS(273)PpT(275)APLSPMSPPGYK•
CT Ser279 [76]
CT Ser282 [76] pY(265)AYFNGCSSPTAPLSPMpS(282)PPGYK•
CT Thr290 LVpT(290)GDRNNSSCR•
CT Ser296 [112] LVTGDRNNpS(296)SCR*
LVTGDRNNpS(296)pS(297)CR•
CT Ser297 [112] LVTGDRNNSpS(297)CR•
CT Ser306 [112] QApS(306)EQNWANYSAEQNR*
QApS(306)EQNWANYpS(314)AEQNR•
CT Tyr313 QASEQNWANpY(313)SAEQNR⊗
CT S314 [16] QASEQNWANYpS(314)AEQNR*
CT S325 [113] MGQAGpS(325)TISNSHAQPFDFPDDSQNAK*
MGQAGpS(325)pT(326)ISNSHAQPFDFPDDSQNAK•
MGQAGpS(325)TIpS(328)NSHAQPFDFPDDSQNAK•
MGQAGpS(325)TISNpS(330)HAQPFDFPDDSQNAK•
MGQAGSTIpS(325)NSHAQPFDFPDDpS(341)QNAKK•
CT S326 MGQAGpS(325)pT(326)ISNSHAQPFDFPDDSQNAK•
MGQAGSpT(326)IpS(228)NSHAQPFDFPDDSQNAK•
MGQAGSpT(326)ISNpS(330)HAQPFDFPDDSQNAK•
MGQAGSpT(326)IpS(328)NSHAQPFDFPDDpS(341)QNAKK•
CT S328 [113] MGQAGSTIpS(328)NSHAQPFDFPDDSQNAK*
MGQAGpS(325)TIpS(328)NSHAQPFDFPDDSQNAK•
MGQAGSpT(326)IpS(328)NSHAQPFDFPDDpS(341)QNAKK•
CT S330 [113] MGQAGSTISNpS(330)HAQPFDFPDDSQNAKK*
MGQAGpS(325)TISNpS(330)HAQPFDFPDDSQNAK•
MGQAGSpT(326)ISNpS(330)HAQPFDFPDDSQNAK•
CT S341 MGQAGSTIpS(325)NSHAQPFDFPDDpS(341)QNAKK•
MGQAGSpT(326)IpS(328)NSHAQPFDFPDDpS(341)QNAKK•
CT S364 [114] VAAGHELQPLAIVDQRPpS(364)SR*
VAAGHELQPLAIVDQRPpS(364)pS(365)RASSR•
KVAAGHELQPLAIVDQRPpS(364)pS(365)RApS(368)SR•
CT S365 [115] VAAGHELQPLAIVDQRPSpS(365)R*
VAAGHELQPLAIVDQRPSpS(365)RApS(368)SR*
VAAGHELQPLAIVDQRPSpS(365)RASpS(369)R*
CT S368 [116] VAAGHELQPLAIVDQRPSpSRApS(368)SR*
VAAGHELQPLAIVDQRPSpS(365)RApS(368)SR*
CT S369 [115] VAAGHELQPLAIVDQRPSpSRASpS(369)R*
VAAGHELQPLAIVDQRPSpS(365)RASpS(369)R*
CT S372 [117]
CT S373 [115]
*[79], •[34], °[118], ⊗[119]. Summary of Cx43 site and multi-site phosphorylation, using respective hypothesis-driven and phosphoproteomic strategies.
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role in complementing a tissues' physiology, these authors also
found some broadly expressed proteins, such as Cx43, were variably
modiﬁed [34]. However, as a targeted technique to track and reliably
quantify sites of modiﬁcation across multiple tissues has not yet been
applied, it should be cautioned that the lack of a phosphorylated spe-
cies within a tissue may not necessarily be reﬂective of the physiolog-
ical state, but a technical constraint linked to sample complexity.
Regardless of these perceived limitations, using phosphopeptide
datasets generated by the proteomic community, we have compiled
a current set of known individual and multi-site Cx43 phosphopep-
tide sequences.
A large-scale phosphoproteomic analysis of mouse tissues demon-
strated kinase activation loops were targets of phosphorylation,indicative of cross-talk between kinases and phosphates [27]. In
keeping with this view, a notable study by Breitkreutz et al. addition-
ally observed promiscuity between kinases and phosphatases within
more than 1800 interactions [59]. Here, kinases and phosphatase
did not appear to interact in a traditional stepwise cascade, but rather
a myriad of interactions more similar to a “neural network” capable
of computing functions to drive cellular responses. Understanding
how Cxs phosphorylation, subcellular localization and protein–
protein interactions respond to such highly networked signals will
be a particular challenge. The analysis of Cx-protein interactions
thus far [80] shows that Cxs are not only associated with kinases,
but also with a variety of other proteins presumably through
cytoplasmic CT domains. Among these interaction partners are
adherens/tight junctional complex such as beta-catenin [81], v-SRC
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[85], drebrin [86] and tubulin [87], as well as caveolin [88], CCN3
[89] and the transcription factor ZONAB [85,90]. To examine structur-
al inﬂuences, we next classify Cx43 sites according to predicted sec-
ondary structure within regions of protein disorder [91]. Here,
based on the Cx43 sequence, the DisPro server (http://scratch.
proteomics.ics.uci.edu/) was used to calculate disordered secondary
structure and propensity for solvent accessibility. As found in previ-
ous studies for other ‘hub’ proteins [92], we ﬁnd an overwhelming
body of phosphorylation sites within disordered and/or loosely or-
dered sequences (Fig. 4). These segments include Region 1 (disor-
dered): Ser244, Tyr247, Thr250, Thr251, Ser255, Ser257, Ser262, and
Tyr265 Region 2 (loosely ordered): Thr290, Ser296, Ser297, S306,
Y313 and Ser314; Region 3 (disordered): Ser325, Thr326, S328 and
S330; Region 4 (disordered): Ser364, Ser365, Ser368, Ser369, Ser372
and Ser373, which may serve as ‘hotspots’ for intracellular signals.
Protein–protein interactions, phosphorylation and protein disorder
prediction, along with our characterization that intrinsically disor-
dered regions of Cx43 are targets of phosphorylation, further sup-
ports the notion that the Cx43-CT may be a highly ﬂexible sensor
capable of monitoring the overall health of the cell as proposed by
the Kardami and Spray labs [93]. In particular, convergence of these
signaling processes onto Cx43 may help to explain why the CT
alone appears to inﬂuence a seemingly divergent but growing list of
cellular functions including growth control and cell proliferation
[94], migration [95,96], spreading and adhesion in B-lymphocytes
[97] and neural development [2].
7. Understanding kinases and Cx43 sequence multi-site
phosphorylation
Phosphorylation and dephosphorylation are catalyzed by more
than 500 kinases and 100 phosphatases that are in turn regulated
by phosphorylation [34]. With an unprecedented level of detail, rich-
ness of phosphate-based signals is beginning to emerge. However, it
has also become apparent that the identiﬁcation of these events is
quickly out-pacing our ability to assess their function, and the match-
ing speciﬁc sites of phosphorylation with acting kinases still remains
a signiﬁcant challenge. Cx43 contains numerous consensus kinases
sites, among them protein kinase A (PKA), protein kinase C (PKC),
protein tyrosine kinases, mitogen activated protein kinases (MAP ki-
nases), glycogen synthase kinase (GSK), and casein kinase (CK).
To generate insights into multi-site phosphorylation patterns, the
NetPhos informatics server was used to examine consensus sites
(Fig. 5). Heat map analysis revealed the majority of phosphorylation
sites appear to be recognized by multiple kinases. HierarchicalFig. 4. Protein disorder and Cx43 phosphorylation sites. A proportion of phosphorylated res
>0.45 were deﬁned as disorder while regions 0.45>×>0.15 were considered loosely ordere
bioinformatics suite (http://www.ics.uci.edu/~baldig/scratch/).clustering revealed multiple kinases such as CaM-II, GSK and cdc2
having high probability across multiple sites, while others such as
PKB show low-to-negligible phosphorylation potential. Broad pat-
terns for CaMk-II, GSK and cdc2 consensus sites suggest these kinases
could be potentially used to induce massive changes in phosphoryla-
tion state. Indeed, the necessity of a ‘priming’ phosphorylation up-
stream of consensus GSK sites [98] suggests Cx43 itself might serve
as a signaling hub and substrate mediating signal cross-talk between
GSK, other kinases and phosphatases. In line with the convergence of
signaling diversity, some kinases appear to have overlapping consen-
sus residues, while others appear to engage Cx43 through distinctive
patterns of phosphorylation. For example, while PKC (T290, S297,
T325, T326, S364, S368, S372 and S373) and PKA (S244, S296, S306
and S373) largely differ in phosphorylation threshold, cdk5 and
p38MAPK demonstrate similarities in consensus sequences (S255,
S262, S273, S279 and S282). Using similar methods for consensus
prediction, MAPK was conﬁrmed to phosphorylate Cx43 at S255,
S279, and S282 [76], with pS279/282 later shown to be important in
decreasing GJ channel open probability [99]. EGF treatment and
down-stream simulation of MAPK has been found to correlate with
phosphorylation, ubiquitylation and internalization of Cx43 GJs from
the plasma membrane [100]. During mitosis, cdk2 has been found
to moves to the cortical surface of the plasma membrane where it
phosphorylates Cx43 at S255 and S262, and appeared to correlate
with GJ internalization [101,102]. Through similar patterns of multi-
site phosphorylation, is it possible that signal transduction through
either MAPK or cdks, are capable of engaging GJ internalization ma-
chinery? It is obvious much work will be necessary to deﬁne the
mechanisms of multi-site phosphorylation.
An important element of Cx studies is to determine their compo-
sition, sites and order of PTMs. In the heart, ischemia is often accom-
panied by loss of electrical coupling and arrhythmias that coincide
with Cx43 dephosphorylation at intercalated disks [103]. The cycling
of kinase-phosphatase during ischemia has been proposed to play an
important role in GJ remodeling [104,105] and the introduction of
phosphatase inhibitors has been found to change their electropho-
retic mobility [106]. Using a highly speciﬁc antibody for Cx43 phos-
phorylation at S325, S328, and/or S330, Lampe et al. reported that
phosphorylation at these sites became drastically reduced during is-
chemia [107]. The functional consequence of multi-phosphorylation
remains unknown and the speciﬁc order by which Cxs are phosphor-
ylated and dephosphorylated largely remains a mystery. Using pro-
teomic datasets, the presence or lack of phosphate at individual
sites alone or within a multiphosphorylated peptide provides insight
into the order of sequence-dependent dephosphorylation and phos-
phorylation. As an example of how global proteomic datasets can beidues (see Table 2) of Cx43 reside in disordered/loosely ordered sequences. Thresholds
d. Protein disorder predictions were obtained using DisPro [91] of the SCRATCH protein
Fig. 5. Heat map distribution of Cx43 phosphorylation sites demonstrates the diversity of kinase signals. Sites of Cx43 phosphorylation were derived from Table 2, and values for
preference for individual kinases were derived from NetPhosK [120].
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pS328 alone, and with multi-phosphorylated peptides (Table 2), im-
plies these residues are phosphorylated early (and/or dephosphory-
lated late) relative to S326, S330 and S341 (Fig. 6). In this scenario,
experiments working to disrupt Cx43 phosphorylation order, by
substituting phosphorylatable residues in mice or cultured cells,
may yield important insights into the physiological importance of
multi-site phosphorylation. These studies not only conﬁrm multi-
site phosphorylation at S325, S328, and S330 [107], but additionally
provide direct molecular evidence for the co-existence of pS325 with
pS326, and pS325 with pS341.
8. Outlook
As a highly dynamic component of the proteome, Cxs form struc-
tures that trafﬁc from one compartment of the endomembrane system
to another. An important element of understanding Cx regulation is to
determine their structural composition, protein–protein interactions,
PTMs and to comprehend how signals work together as an integrated
system. For Cx43, the early stages of assembly demonstrate the protein
is largely non-phosphorylated, with extensive modiﬁcation occurringFig. 6. Determination of relative order of kinases/phosphatases using phosphoproteomic d
sites can be used to map relative order of Cx43 PTM for kinases (phosphorylation addition,
indicate the order of kinase activity at speciﬁc sites, with the opposite direction implying p
serves as an early event towards multi-site PTM.only after transport to the plasma membrane, however the speciﬁc
sites, order and magnitude of multi-site phosphorylation are poorly re-
solved. The mechanisms of Cx phosphorylation has been historically
been viewed in the literature as one site of modiﬁcation represents
one binary molecular function. The implications of results discussed in
this review are multiple. The recent release of large-scale phosphopro-
teomic datasets currently challenges this dogma by demonstrating Cxs
undergoes multiple levels of multi-site phosphorylation. We propose
this may manifest in a combinatorial phosphorylation or a ‘Cx code’
that may be used to help support the functions of cells and tissues. It
is also evident, that distinct signal transduction pathways also appear
to consolidate onto Cx43 through several phosphorylation-based sig-
naling mechanisms, and a pattern of multi-site phosphorylation has
just begun to emerge (Table 2, Fig. 6). This review also found the prefer-
ential phosphorylation within structurally disordered regions that for
the ﬁrst time reveals the architecture of Cx43 is intimately linked to
multi-site PTMs. Using a variety of bioinformatic tools and peer-
reviewed large-scale phosphoproteomic datasets, we demonstrate the
principal GJ subunit, Cx43, likely serves as a highly integrated hub capa-
ble of consolidating a variety of phosphate-based signaling cascades. A
fundamental question that remains unanswered is what are the sites,atasets. By transitive relationships, the presence or lack phosphorylation at individual
red arrow) and phosphatases (blue arrow). At individual congruent sites, black arrows
hosphate removal by phosphatases. In this model, phosphorylation at S325 and S328
32 V.C. Chen et al. / Biochimica et Biophysica Acta 1828 (2013) 23–34sequence and order, and how these complex events come together to
inﬂuence Cx subunits and physiology.
Within the context of a Cx life-cycle, a particular challenge of
studying phosphorylation arises from the difﬁculties of isolating spe-
ciﬁc stages of GJ/Cx maturation. The regulation of Cx subunits appears
to be incredibly complex, and we anticipate that proteomic technolo-
gies and chemical biology will have an increasing role in the interro-
gation of protein-based signals. Therefore, when considering
interactions and PTMs, it will be important to examine these events
within the context of trafﬁcking subunits and ideally within the con-
text of an integrated network — possibly using GJ intercellular com-
munication as an output for system-level models. In the case of
functionally distinct, location-speciﬁc modiﬁcations and interactions,
one would expect initiation of these events at fairly precise locations
within the cell. It is anticipated that the subcellular fractionation and
the systematic examination using discovery proteomics, targeted
technologies (such as MRM) and quantitative proteomics together
will provide a valuable framework towards fully understanding Cxs.
Although an unprecedented view of Cx multi-site phosphorylation
is emerging, it appears we have only scratched the surface towards
understanding the Cx code.
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